Document is current
Any future updates will be listed below
-
Authors
van den Hil, L. C. L.
Mommers, E. H. H.
Bosmans, J. W. A. M.
Morales‐Conde, S.
Gómez‐Gil, V.
LeBlanc, K.
Vanlander, A.
Reynvoet, E.
Berrevoet, F.
Gruber‐Blum, S.
Altinli, E.
Deeken, C. R.
Fortelny, R. H.
Greve, J. W.
Chiers, K.
Kaufmann, R.
Lange, J. F.
Klinge, U.
Miserez, M.
Petter‐Puchner, A. H.
Schreinemacher, M. H. F.
Bouvy, N. D.
- License Information
-
More Information
Article History
First Online: 4 July 2020
Compliance with ethical standards
:
: SM declares conflicts of interest, since he has received speaker honorarium from Bard, Medtronic, Stryker, Storz and Ethicon. Furthermore, he is a member of the Advisory Board from Bard. However, this fact did not influence the content of this paper. CD declares conflicts of interest, since she received consulting fees from Colorade Therapeutics, TELA Bio, Ethicon, Musculoskeletal Transplant Foundation, Biom'Up, CR Bard and Surgical Innovation Associates. In addition, she has a patent on Bionanocomposite for tissue regeneration and soft tissue repair issued. However, these facts did not influence the content of this paper. LH, EM, JB, VG, KL, AV, ER, FB, SG, EA, RF, JG, KC, RK, JL, UK, MM, AP, MS, NB declare no conflict of interest that influences the content of this paper.
: This article does not contain any studies with human participants performed by any of the authors.
